Cns & Neurological Disorders-drug Targets

雜志介紹

Cns & Neurological Disorders-drug Targets雜志介紹

《Cns & Neurological Disorders-drug Targets》是一本以English為主的未開放獲取國際優秀期刊，中文名稱中樞神經系統和神經系統疾病-藥物靶點，本刊主要出版、報道醫學-NEUROSCIENCES領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.7，最新CiteScore 指數為5.1。

本刊近期中國學者發表的論文主要有：

• Brain Damage in the Preterm Infant: Clinical Aspects and Recent Progress in the Prevention and Treatment

  Author: Xie, Yixuan; Yang, Yue; Yuan, Tianming

• Role of G-Proteins and GPCR-Mediated Signalling in Neuropathophysiology

  Author: Rahman, Md. Mominur; Mim, Sadia Afsana; Islam, Md. Rezaul; Sultana, Nasrin; Ahmed, Muniruddin; Kamal, Mohammad Amjad

• Danshensu Enhances Cerebral Angiogenesis in Mice by Regulating the PI3K/Akt/Mtor/VEGF Signaling Axis

  Author: Jia, Hongning; Qi, Xiaoyuan; Wu, Huijun; Wang, Jianping

• The Protective Effect of Vitexin Compound B-1 on Rat Cerebral I/R Injury through a Mechanism Involving Modulation of miR-92b/NOX4 Pathway

  Author: Hu, Zhong-Yang; Yang, Zhong-Bao; Zhang, Ruxu; Luo, Xiu-Ju; Peng, Jun

英文介紹

Cns & Neurological Disorders-drug Targets雜志英文介紹

Aims & Scope

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.

CNS & Neurological Disorders - Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts for publication original research articles, letters, reviews and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.